Disclaimer: This article is for educational purposes only and does not replace individual medical advice. Tamoxifen is a prescription-only medicine in Australia. Always discuss treatment decisions with your GP, oncologist, or breast physician.
If you or someone you love has heard the words “hormone receptor-positive breast cancer” or “high risk of breast cancer”, you know the fear. You lie awake wondering: Will it come back? Will I be around for my children, my partner, my retirement? You may also have heard worrying things about side effects — hot flushes, vaginal dryness, mood changes, bone thinning, and the effect on fertility. These fears are real, and they matter.
But here is what I want you to know as a doctor: tamoxifen has been one of the most important cancer medicines in Australian medicine for more than 40 years. It is not new, it is not experimental, and it is not unproven. For many people, tamoxifen is the difference between early, curable breast cancer and a recurrence that changes everything. If you are over 30 and facing a breast cancer diagnosis or high-risk result, this is a conversation you deserve to have.
Tamoxifen belongs to a class of medicines called selective oestrogen receptor modulators (SERMs). In breast tissue, it blocks oestrogen from fuelling hormone-sensitive cancer cells. In other tissues, such as bone and the uterus, it can act more like oestrogen. This dual action explains both its benefits and some side effects.
In Australia, tamoxifen is approved by the Therapeutic Goods Administration (TGA) and is widely prescribed. Most patients take 20 mg once daily as a tablet, usually for 5 to 10 years depending on individual risk.
| Approved use in Australia | Why it matters |
|---|---|
| Early hormone receptor-positive breast cancer in premenopausal and postmenopausal women | Reduces the risk of recurrence and improves overall survival after surgery, chemotherapy, and radiotherapy. |
| Advanced or metastatic hormone receptor-positive breast cancer | Slows cancer growth and improves quality of life when the disease is not curable but is treatable. |
| Ductal carcinoma in situ (DCIS) | Lowers the chance of invasive breast cancer developing after local treatment. |
| Breast cancer risk reduction in high-risk women | Used as preventive therapy for women with a strong family history or confirmed high-risk genetic profile. |
| Male breast cancer | Effective in hormone receptor-positive breast cancer in men. |
In Australia, tamoxifen is available through the Pharmaceutical Benefits Scheme (PBS) for eligible patients, making it affordable. Common brands include Nolvadex-D, Genox, Tamosin, and Tamoxen, as well as generic tamoxifen citrate tablets.
Some people think tamoxifen is an “old drug” that will soon be replaced. That is not true. In fact, tamoxifen is still a cornerstone of breast cancer care, and new research is making it smarter and more personalised.
For Australian patients, this means tamoxifen is not going anywhere. It remains highly effective, affordable, and increasingly individualised.
“Off-label” means a medicine is used for a condition that is not part of its TGA-approved registration. Doctors sometimes prescribe tamoxifen off-label when the evidence supports it. In Australia, the most recognised off-label uses include:
Off-label prescribing should always be undertaken by a doctor with experience in the specific condition, and you should understand the potential risks and benefits.
This is an excellent question because bone health matters greatly to people over 30, especially women approaching menopause.
In postmenopausal women, tamoxifen has an oestrogen-like effect on bone. It can help preserve bone mineral density and may reduce the risk of vertebral fractures. This is a potential bonus for postmenopausal women already taking tamoxifen for breast cancer. However, tamoxifen is not TGA-approved or PBS-subsidised for osteoporosis prevention in Australia, and it is not a first-line choice. Medicines such as bisphosphonates, denosumab, or raloxifene are usually preferred for osteoporosis.
In premenopausal women, tamoxifen may actually reduce bone mineral density because it blocks the stronger natural oestrogen from protecting bone. For this reason, premenopausal women on tamoxifen should have their bone health monitored, especially if they also receive ovarian suppression or chemotherapy. Calcium, vitamin D, weight-bearing exercise, and sometimes bone-protective medicines are important.
Bottom line: Do not start tamoxifen solely to prevent osteoporosis. But if you are already taking tamoxifen after menopause, it may offer some bone protection — one more reason to stay on track.
Your tamoxifen tablets will have an expiry date printed on the blister pack and the box. In Australia, the shelf life is typically 2 to 3 years from the date of manufacture when stored correctly. Always check the expiry date before use and never take expired medicine, as it may be less effective.
Store tamoxifen in a cool, dry place below 25°C, away from direct sunlight and moisture. Do not store it in the bathroom or car glovebox. If the tablets change colour, smell unusual, or become damp, return them to your pharmacist for safe disposal.
Vaginal dryness and discomfort during intimacy are common and distressing side effects of tamoxifen, especially for women over 40. This is because tamoxifen blocks oestrogen in vaginal tissues. The good news is that lubricants and vaginal moisturisers are safe to use with tamoxifen and can significantly improve comfort and intimacy.
| Type | Safe examples | Tips |
|---|---|---|
| Water-based lubricants | K-Y Jelly, Sylk, YES WB, Astroglide | Safe with condoms and silicone toys; may need reapplication. |
| Silicone-based lubricants | Pjur, Wet Platinum, YES OB | Longer lasting; safe with latex condoms; avoid with silicone sex toys. |
| Vaginal moisturisers | Replens, YES VM, Vagisil ProHydrate | Use regularly, not only before sex, to restore moisture. |
Avoid petroleum-based products such as petroleum jelly, baby oil, or mineral oil for vaginal lubrication. They can irritate the vagina and weaken condoms. Also choose products without strong perfumes, warming agents, or high glycerin content if you are prone to thrush or irritation. These lubricants do not interact with tamoxifen, so you can use them confidently.
Hot flushes are one of the most common reasons women consider stopping tamoxifen. Please do not stop without talking to your doctor — there are effective ways to manage them.
Important: Avoid antidepressants such as paroxetine, fluoxetine, and bupropion if you are taking tamoxifen, because they may inhibit the liver enzyme CYP2D6 and reduce tamoxifen’s effectiveness. Venlafaxine and desvenlafaxine are generally preferred. Always ask your doctor or pharmacist before starting any new medicine.
This is a major worry for women diagnosed in their 30s or early 40s. Here is what you need to know.
Tamoxifen can make your periods irregular or stop them temporarily, especially in the first year. However, tamoxifen does not necessarily cause permanent infertility. Many women resume regular cycles after stopping treatment, but fertility depends heavily on age, chemotherapy exposure, and ovarian reserve.
Interestingly, tamoxifen is sometimes used off-label by fertility specialists to induce ovulation because it can stimulate the ovaries in women with irregular ovulation. However, if you are taking tamoxifen for breast cancer, you must not become pregnant during treatment because tamoxifen can harm a developing baby. Effective non-hormonal contraception, such as condoms or a copper IUD, is essential.
If you want to have a baby in the future, discuss fertility preservation before starting tamoxifen. Options such as egg or embryo freezing may be possible. After finishing tamoxifen, you will usually need to wait a washout period before trying to conceive — commonly around 2 to 3 months. This is a decision to make with your oncologist and fertility specialist.
If you have been diagnosed with hormone receptor-positive breast cancer, DCIS, or you are at high risk, tamoxifen may be one of the most powerful tools available to protect your future. It is affordable, extensively researched, and available on the PBS in Australia.
Here is how to take the next step:
You do not have to live in fear of breast cancer recurrence. With tamoxifen, millions of Australians have taken back control of their health, their bodies, and their futures. If you are over 30 and this medicine might suit you, speak to your doctor today. The right time to act is now.
This article is a general guide and does not replace professional medical advice. Tamoxifen is a Schedule 4 prescription medicine in Australia. Always consult a qualified health professional before starting, stopping, or changing any treatment.